Bolt Biotherapeutics (BOLT)

Currency in USD
6.080
+0.170(+2.88%)
Closed·
6.0800.000(0.00%)
·
BOLT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.9156.200
52 wk Range
3.1007.780
Key Statistics
Prev. Close
5.91
Open
6.03
Day's Range
5.915-6.2
52 wk Range
3.1-7.78
Volume
28.12K
Average Volume (3m)
249.81K
1-Year Change
33.0416%
Book Value / Share
NA
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BOLT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Strong return over the last month

Bolt Biotherapeutics News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Rodman & Renshaw
Buy22.00+261.84%-New CoverageMay 28, 2026
Jones Trading
Hold---New CoverageApr 06, 2026

Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
-2.25 / -3.52
Revenue / Forecast
450K / 426.25K
EPS Revisions
Last 90 days

Compare BOLT to Peers and Sector

Metrics to compare
BOLT
Peers
Sector
Relationship
P/E Ratio
-−1.6x−0.2x
PEG Ratio
-−0.040.00
Price/Book
1.8x2.0x2.6x
Price / LTM Sales
-9.5x2.8x
Upside (Analyst Target)
-148.8%65.0%
Fair Value Upside
Unlock25.3%9.6%Unlock

Bolt Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company offers product candidates and platform technologies, including PRA-216, BDC-4182, a Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; the Boltbody Immune-Stimulating Antibody Conjugate (ISAC) platform, and the INSPIRE platform. It serves patients, clinical investigators, and biopharmaceutical partners. The company is based in Redwood City, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
900.94K34.84%5.48M
Public Companies & Retail Investors
1.68M65.16%10.24M
Total
2.59M100.00%15.72M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Coastlands Capital LP17.88%462,4162,811
Coastlands Capital Partners LP15.95%412,4162,507

People Also Watch

1.100
WFF
-2.65%
9.65
AIOK
-6.76%
1.280
DKI
-7.25%
2.140
XLAB
-5.73%
3.370
CLRO
-3.16%

FAQ

What Is the Bolt (BOLT) Stock Price Today?

The Bolt stock price today is 6.080 USD.

What Stock Exchange Does Bolt Trade On?

Bolt is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Bolt?

The stock symbol for Bolt is "BOLT."

What Is the Bolt Market Cap?

As of today, Bolt market cap is 15.280M USD.

When Is the Next Bolt Earnings Date?

Bolt will release its next earnings report on Mar 31, 2027.

From a Technical Analysis Perspective, Is BOLT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Bolt Stock Split?

Bolt has split 1 times.

What is the current trading status of Bolt (BOLT)?

As of Nov 14, 2026, Bolt (BOLT) is trading at a price of 6.080 USD, with a previous close of 5.910 USD. The stock has fluctuated within a day range of 5.915 USD to 6.200 USD, while its 52-week range spans from 3.100 USD to 7.780 USD.

What Is the BOLT Premarket Price?

BOLT's last pre-market stock price is 5.780 USD. The pre-market share volume is 50.000, and the stock has decreased by -0.130, or -2.200%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.